Evaluating Opportunities to Improve ADC Bioanalytical Efficiency & Understand Future Directions for ADC Immunogenicity Characterization
- Explaining challenges in ADC PK characterization across monoclonal antibody, free payload, and conjugate
- Assessing bioanalytical and regulatory strategy required for ADC bioanalysis in late-stage clinical development
- Tackling immunogenicity assessment of ADCs: What have we learned so far and what is still to come?